go back

Idecabtagene Vicleucel (Abecma) CAR-T Therapy

Hawaii rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Professionalmedian $537,032 · 10th to 90th $537,032 to $630,957
$1Mprofessional $537,032

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
HMSA
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$537,031.80
Typical High
$537,031.80
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$616,595.00
Median
$676,082.98
Typical High
$1,096,478.20